Keywords: حفظ کردن; BM; brain metastasis; AE; adverse event; CI; confidence interval; CTLA4; cytotoxic T-lymphocyte antigen-4; CT; computed-tomography; GPA; Graded Prognostic Assessment score; IORR; intracerebral objective response rate; IQR; interquartile range; NSCLC; nonâ
مقالات ISI حفظ کردن (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: حفظ کردن; CI; confidential interval; CT; computed tomography; DECT; dual-energy computed tomography; GSI; gemstone spectral imaging; HU; hounsfield unit; NSCLC; non-small cell lung cancer; OR; odds ratio; RECIST; response evaluation criteria in solid tumors; ROC; r
Keywords: حفظ کردن; CT; computed tomography; PET; positron emission tomography; PA; posterior-anterior; CECT; contrast enhanced computed tomography; 18[F]-FDG; 18[F]-fluorodeoxyglucose; ROI; region of interest; MRI; magnetic resonance imaging; RECIST; response evaluation cri
Keywords: حفظ کردن; CI; confidence interval; CR; complete response; DC; disease control; OS; overall survival; PD; progressive disease; PR; partial response; RECIST; Response Evaluation Criteria in Solid Tumors; SD; stable disease; STS; soft tissue sarcoma; TARE; transarteri
Keywords: حفظ کردن; CTP; computed tomography perfusion; NSCLC; non-small-cell-lung cancer; CTx; chemotherapy; RTx; radiotherapy; BF; blood flow; BV; blood volume; PMB; permeability; MTT; mean transit time; MVD; microvessel density; VEGF; vascular endothelial growth factor; R
Keywords: حفظ کردن; metastatic breast cancer; MBC; lobaplatin and gemcitabine; GL; lobaplatin and vinorelbine; NL; cisplatin and gemcitabine; GP; cisplatin and vinorelbine; NP; progression-free survival; PFS; overall survival; OS; response rate; RR; platinum-based compounds;
Keywords: حفظ کردن; DICOM; Digital Imaging and Communications in Medicine; GEMM; genetically engineered mouse model; KP; KRAS TP53; micro-CT; micro-computed tomography; MTC; mass of the thoracic cavity; PLK1; polo-like kinase 1; RECIST; Response Evaluation Criteria in Soli
Keywords: حفظ کردن; PD-1; programed cell death-1; PD-L1; programmed cell death ligand 1; NSCLC; non-small-cell lung cancer; OS; overall survival; PFS; progression-free survival; ORR; objective response rate; irAEs; immune-related adverse events; RECIST; response evaluation c
Keywords: حفظ کردن; BACE; bronchial arterial chemoembolization; CBM; China biological medicine database; CNKI; China national knowledge infrastructure database; CENTRAL; Cochrane Central Register of Controlled Trials; Chi-CTR; Chinese clinical trial registry; DCR; disease co
Keywords: حفظ کردن; CI; confidence interval; CRLM; colorectal cancer liver metastases; 18F-FDG; 18F-fluorodeoxyglucose; HR; hazard ratio; LTD; longest tumor diameter; NTL; nontarget lesion; OS; overall survival; PET; positron emission tomography; RE; radioembolization; RECIS
Keywords: حفظ کردن; ALK; Anaplastic Lymphoma Kinase; CI; Confidence interval; CT; Computerized Tomography; EGFR; Epidermal Growth Factor Receptor; ESMO; European Society of Medical Oncology; 18F-FDG; Fluorodeoxyglucose; IQR; Interquartile range; MATV; Metabolic Active Tumor
Keywords: حفظ کردن; EORTC; European Organization for Research and Treatment of Cancer; NCI-MATCH; National Cancer Institute- Molecular Analysis for Therapy Choice; RECIST; Response Evaluation Criteria In Solid Tumors; SITC; Society for ImmunoTherapy of Cancer; SPECTA; Screen
Keywords: حفظ کردن; Immunoassay; Serum biomarker; Cancer; Follow-up; Prognosis; Histotype; HE4; human epididymis protein 4; OC; ovarian cancer; CA125; carbohydrate antigen 125; HR; hazard ratio; PFS; progression-free survival; NCCN; National Comprehensive Cancer Network; GCI
Keywords: حفظ کردن; 5FU; 5-fluorouracil; 95%CI; 95% confidence interval; AA; amino acid; AFP; alpha fetoprotein; AML; actue myeloid leukemia; Ang2; angiopoietin 2; ATP; adenosine triphosphate; BCLC; Barcelona-Clinic Liver Cancer classification; BSC; best supportive care; CAP
Keywords: حفظ کردن; NSCLC; non small-cell lung cancer; EGFR; epidermal growth factor receptor; TKI; tyrosine kinase inhibitor; PFS; progression-free survival; ECOG; Eastern Cooperative Oncology Group; RECIST; Response Evaluation Criteria in Solid Tumors; ECG; electrocardiogr
Keywords: حفظ کردن; DWI; Diffusion weighted magnetic resonance imaging; CT; Computed Tomography; RECIST; The Response Evaluation Criteria in Solid Tumours (RECIST); MRI; Magnetic Resonance Imaging; ADC; Apparent Diffusion Coefficient; DWI; CT; RECIST1.1; Biomarker; Clinical
Keywords: حفظ کردن; Castration-resistant; Measurable tumor; Metastatic; Prostate cancer; RECIST;
Keywords: حفظ کردن; TACE; Transarterial Chemoembolization; cTACE; conventional Transarterial Chemoembolization; HCC; hepatocellular carcinoma; EASL; European Association for the Study of the Liver Guidelines; qEASL; 3D quantitative European Association for the Study of the L
Keywords: حفظ کردن; Clinical trial; cancer imaging; study design; statistical analysis; ACRIN; American College of Radiology Imaging Network; CT; computed tomography; ER; estrogen receptor; FDG; [18F]-fluorodeoxyglucose; FDG-PET; positron emission tomography with [18F]-fluor
Keywords: حفظ کردن; cfDNA; cell-free DNA; CNI; copy number instability; ctDNA; circulating tumor cell-free DNA; ddPCR; droplet digital PCR; GcfDNA; graft-derived cell-free DNA; LC-MS/MS; liquid chromatography tandem mass spectrometry; MIC; minimum inhibitory concentration; N
Keywords: حفظ کردن; protein kinases; thyroid carcinoma; vascular endothelial growth factor; oncogenes; RECIST;
Keywords: حفظ کردن; Gastrointestinal stromal tumor; Sunitinib; Tumor response criteria; RECIST; Choi
Keywords: حفظ کردن; Erythropoietin; Stem cell; Traumatic brain injury; EPO; Erythropoietin; GFAP; Glial fibrillary acidic protein; H&E; Hematoxylin and eosin; MRI; Magnetic resonance imaging; MSC; Mesenchymal stem cell; RECIST; Response Evaluation Criteria in Solid Tumors; S
Keywords: حفظ کردن; Local control; Spine radiosurgery; Spine surgery; Tumor; Wound infection; CT; Computed tomography; CTV; Clinical target volume; DRR; Digitally reconstructed radiograph; ESCC; Epidural spinal cord compression; IM; Infrared markers; MESCC; Metastatic epidur
Keywords: حفظ کردن; EC; esophageal cancer; EADC; esophageal adenocarcinoma; ESCC; esophageal squamous cell carcinoma; DMET; drug metabolism enzymes and transporters; ROC; receiver operating characteristics; AUC; area under the curve; RECIST; response evaluation criteria in s
Keywords: حفظ کردن; ECOG; Eastern Cooperative Oncology Group; GGT; γ-glutamyltransferase; HR; hazard ratio; LdBM; liver dominant breast metastases; OS; overall survival; RECIST; Response Evaluation Criteria In Solid Tumors; TARE; transarterial radioembolization; TTEP; time
Keywords: حفظ کردن; Lung tumor; RECIST; Computed tomography; Perfusion; PET-CT;
Keywords: حفظ کردن; SBRT; stereotactic body radiation therapy; HCC; hepatocellular carcinoma; RECIST; response evaluation criteria in solid tumors; CTCAE; common terminology criteria for adverse events; LC; local control; OS; overall survival; PFS; progression-free survival;
Keywords: حفظ کردن; Clinical trials; RECIST; cloud computing; consensus; lesion volume; biomarkers; volume thresholds;
Keywords: حفظ کردن; Natural language processing; RECIST; Radiology report; Oncologic measurement; Information correlation;
Keywords: حفظ کردن; RECIST; Tumour assessment criteria; Targeted agents; FDG-PET; Advanced MR techniques;
Keywords: حفظ کردن; Breast neoplasm; computed tomography; liver metastasis; RECIST; Yttrium-90;
Keywords: حفظ کردن; BSA; body surface area; CEA; carcinoembryonic antigen; DWL; whole-liver absorbed dose; mCRC; metastatic colorectal carcinoma; RECIST; Response Evaluation Criteria in Solid Tumors; REILD; radioembolization-induced liver disease; SPECT; single photon emissi
Keywords: حفظ کردن; Gastrointestinal stromal tumor; Neoadjuvant imatinib; Surgery; Imaging; RECIST
Keywords: حفظ کردن; Elongation; 3D; Volume; RECIST; Response; Imatinib; GIST; Liver metastases; Morphology; Orientation
Keywords: حفظ کردن; EGFR; epidermal growth factor receptor; NSCLC; non-small cell lung cancer; TKI; tyrosine kinase inhibitor; WT; wild type; KRAS; Kirsten RNA associated rat sarcoma 2 virus gene; PTEN; phosphatase and tensin homolog; HGF; hepatocyte growth factor; IGF1R; in
Keywords: حفظ کردن; Structured reporting; quantitative imaging; Annotation and Image Markup; AIM; RECIST;
Keywords: حفظ کردن; Metastatic renal cancer; Anti-angiogenic; Tumour response; RECIST; Functional imaging
Keywords: حفظ کردن; EORTC; Cancer; Bone; Metastases; Imaging; Treatment; Response; RECIST; MRI; PET;
Keywords: حفظ کردن; Hepatocellular carcinoma; Systemic treatment; Patients selection; Management; Tumour response; RECIST
Keywords: حفظ کردن; AAV; adeno-associated viruses; Ad6; adenovirus serotype 6; ABCB5Â +; ATP-binding cassette sub-family B member 5; ALDH; aldehyde dehydrogenase; AML; acute myeloid leukemia; APCs; antigen presenting cells; B7.1; (CD80) cluster of differentiation 80; BCG; Ba
Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines
Keywords: حفظ کردن; ADRs; adverse drug reactions; AMI; astragalus membranaceus injection; CNKI; China national knowledge infrastructure database; CBM; China biological medicine database; CR; complete response; CI; confidence interval; CTCAE 3.0; Common Terminology Criteria f
Occurrence and significance of morphologic changes in patients with metastatic triple negative breast cancer treated with Cabozantinib
Keywords: حفظ کردن; Cabozantinib; Breast cancer; Tumor response criteria; RECIST; Choi;
Tumor response to neoadjuvant chemotherapy in patients with esophageal cancer assessed with CT and FDG-PET/CT - RECIST 1.1 vs. PERCIST 1.0
Keywords: حفظ کردن; FDG-PET/CT; RECIST; PERCIST; Esophagus cancer;
Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer
Keywords: حفظ کردن; ALK; anaplastic lymphoma kinase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BSA; body surface area; Ccr; creatinine clearance; CI; confidence interval; CR; complete response; CTCAE; common terminology criteria for adverse events; DCR;
A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease
Keywords: حفظ کردن; ILD; interstitial lung disease; IPF; idiopathic pulmonary fibrosis; AE; acute exacerbation; AE-ILD; acute exacerbation of interstitial lung disease; NSCLC; non-small cell lung cancer; S-1; tegafur-gimeracil-oteracil potassium; CBDCA; carboplatin; RECIST;
Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study
Keywords: حفظ کردن; CA; cancer antigen; CI; confidence interval; ECOG; Eastern Cooperative Oncology Group; ICC; intrahepatic cholangiocarcinoma; INR; international normalized ratio; MELD; Model for End-Stage Liver Disease; OS; overall survival; RECIST; Response Evaluation Cr
Clinical Value of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Response Evaluation after Primary Treatment of Advanced Epithelial Ovarian Cancer
Keywords: حفظ کردن; Epithelial ovarian cancer; FDG; PET/CT; RECIST; response evaluation;
Highly sensitive detection and mutational analysis of lung cancer circulating tumor cells using integrated combined immunomagnetic beads with a droplet digital PCR chip
Keywords: حفظ کردن; NSCLC; non-small cell lung cancer; SCC; lung squamous cell carcinoma; SCLC; small cell lung cancer; AC; adenocarcinoma; RECIST; response evaluation criteria in solid tumors; Circulating tumor cells (CTCs); Immuno-magnetic beads; Epithelial protein; Lung c
Diagnostic validation and interpretation of longitudinal circulating biomarkers using a biomarker response characteristic plot
Keywords: حفظ کردن; BReC plot; biomarker response characteristic plot; CEA; carcinoembryonic antigen; Cyfra 21.1; cytokeratin 19 fragment; RECIST; response evaluation criteria in solid tumors; CR; complete remission; PR; partial remission; SD; stable disease; PD; progressive